BioCentury | Apr 15, 2013
Company News

ID Biomedical, University of British Columbia deal

ID Biomedical Corp. (IDBEF), Vancouver, B.C. University of British Columbia, Vancouver, B.C. Business: Infectious diseases/AIDS IDBEF's ID Vaccine Corp. subsidiary (Seattle, Wash.) will collaborate with the university to develop vaccines for bacterial infection, initially targeting...
BioCentury | Apr 15, 2013
Company News

ID Biomedical, The Collaborative BioAlliance deal

...I testing. ID Vaccine intends to file an IND in the first quarter of 1998. ID Biomedical Corp....
BioCentury | Apr 15, 2013
Company News

ID Biomedical scientific advisory board update

ID Biomedical Corp. (IDBEF), Vancouver, B.C. Business: Diagnostics/Imaging, Infectious diseases/AIDS Appointed to the scientific advisory board of IDBEF's ID Vaccine Corp. subsidiary (Kirkland Wash.): Emil Gotschlich, M.D., professor, senior physician and VP for medical sciences...
BioCentury | Apr 15, 2013
Company News

ID Biomedical, University of Arkansas deal

...the feasibility of using CPT to detect TB using a probe developed at the university. ID Biomedical Corp....
BioCentury | Apr 15, 2013
Clinical News

Rapid culture test for the mecA gene for antibiotic resistance data

...weeks. The company plans to submit a 510(k) application to the FDA by early October. ID Biomedical Corp....
BioCentury | Jan 15, 2007
Company News

Napo board of directors update

...Inc. (LSE:NAPL), South San Francisco, Calif. Business: Gastrointestinal Appointed: Mustapha Leavenworth Bakali, former COO of ID Biomedical Corp. WIR...
BioCentury | Oct 9, 2006
Clinical News

FluLaval regulatory update

...the vaccine, which is marketed in Canada as Fluviral , through its 2005 acquisition of ID Biomedical Corp....
BioCentury | Oct 6, 2006
Company News

FDA approves GSK's FluLaval

...the vaccine, which is marketed in Canada as Fluviral , through its 2005 acquisition of ID Biomedical...
BioCentury | Sep 25, 2006
Company News

Phoqus Ltd. board of directors update

...Phoqus Ltd. (LSE:PQS), Kent, U.K. Business: Drug delivery Appointed: Mustapha Leavenworth Bakali, former COO of ID Biomedical Corp. WIR...
BioCentury | Jun 19, 2006
Finance

Millennium M&A comps

...$1.3B in cash 2005 Genzyme Ilex Oncology $20.80 $26.00 25% $1B in stock 2005 GlaxoSmithKline ID Biomedical...
Items per page:
1 - 10 of 211
BioCentury | Apr 15, 2013
Company News

ID Biomedical, University of British Columbia deal

ID Biomedical Corp. (IDBEF), Vancouver, B.C. University of British Columbia, Vancouver, B.C. Business: Infectious diseases/AIDS IDBEF's ID Vaccine Corp. subsidiary (Seattle, Wash.) will collaborate with the university to develop vaccines for bacterial infection, initially targeting...
BioCentury | Apr 15, 2013
Company News

ID Biomedical, The Collaborative BioAlliance deal

...I testing. ID Vaccine intends to file an IND in the first quarter of 1998. ID Biomedical Corp....
BioCentury | Apr 15, 2013
Company News

ID Biomedical scientific advisory board update

ID Biomedical Corp. (IDBEF), Vancouver, B.C. Business: Diagnostics/Imaging, Infectious diseases/AIDS Appointed to the scientific advisory board of IDBEF's ID Vaccine Corp. subsidiary (Kirkland Wash.): Emil Gotschlich, M.D., professor, senior physician and VP for medical sciences...
BioCentury | Apr 15, 2013
Company News

ID Biomedical, University of Arkansas deal

...the feasibility of using CPT to detect TB using a probe developed at the university. ID Biomedical Corp....
BioCentury | Apr 15, 2013
Clinical News

Rapid culture test for the mecA gene for antibiotic resistance data

...weeks. The company plans to submit a 510(k) application to the FDA by early October. ID Biomedical Corp....
BioCentury | Jan 15, 2007
Company News

Napo board of directors update

...Inc. (LSE:NAPL), South San Francisco, Calif. Business: Gastrointestinal Appointed: Mustapha Leavenworth Bakali, former COO of ID Biomedical Corp. WIR...
BioCentury | Oct 9, 2006
Clinical News

FluLaval regulatory update

...the vaccine, which is marketed in Canada as Fluviral , through its 2005 acquisition of ID Biomedical Corp....
BioCentury | Oct 6, 2006
Company News

FDA approves GSK's FluLaval

...the vaccine, which is marketed in Canada as Fluviral , through its 2005 acquisition of ID Biomedical...
BioCentury | Sep 25, 2006
Company News

Phoqus Ltd. board of directors update

...Phoqus Ltd. (LSE:PQS), Kent, U.K. Business: Drug delivery Appointed: Mustapha Leavenworth Bakali, former COO of ID Biomedical Corp. WIR...
BioCentury | Jun 19, 2006
Finance

Millennium M&A comps

...$1.3B in cash 2005 Genzyme Ilex Oncology $20.80 $26.00 25% $1B in stock 2005 GlaxoSmithKline ID Biomedical...
Items per page:
1 - 10 of 211